CADPS2 antibody (AA 435-510) (FITC)

Catalog No. ABIN1391636

Product Details anti-CADPS2 Antibody (FITC)

Target: CADPS2 (Ca++-Dependent Secretion Activator 2 (CADPS2))

Binding Specificity: AA 435-510

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CADPS2 antibody is conjugated to FITC

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Predicted Reactivity: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CADPS2

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for CADPS2

Target: CADPS2 (Ca++-Dependent Secretion Activator 2 (CADPS2))

Alternative Name: CADPS2 (CADPS2 Products)

Synonyms: RGD1559440 antibody, A230044C21Rik antibody, Caps-2 antibody, Caps2 antibody, Cpd2 antibody, caps antibody, cpd2 antibody, zgc:110135 antibody, calcium dependent secretion activator 2 antibody, Ca2+-dependent activator protein for secretion 2 antibody, Ca++-dependent secretion activator 2 antibody, CADPS2 antibody, Cadps2 antibody, cadps2 antibody

Background:

Synonyms: Cadps2, Calcium-dependent activator protein for secretion 2, Calcium-dependent secretion activator 2, CAPS2, CAPS2_HUMAN.

Background: Calcium-dependent secretion activators (CAPS-1 and CAPS-2) are calcium-binding proteins that direct neurotransmitter and neuropeptide-filled vesicles to the cell membrane for secretory granule exocytosis. Both CAPS-1 and CAPS-2 are expressed primarily in the brain where they regulate the secretion of various substances. The CAPS proteins contain a PH domain that is essential for regulation of exocytosis, as well as regulation of phospholipid binding. Through their regulation of neurotrophin release from granule cells, CAPS proteins help to regulate cell fate during neuronal development. CAPS-1 is thought to regulate catecholamine release from neuronal cells, while CAPS-2 is thought to regulate release of both brain-derived neurotrophic factor and neurotrophin-3 from granule cells. Defects in the genes encoding CAPS-1 and CAPS-2 are implicated in impaired cerebral development and autism.

Pathways: Synaptic Vesicle Exocytosis